Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Multicentric Evaluation of the AqueSys XEN Implant in Moderate Primary Open Angle Glaucoma Subjects

NCT02006693 is registered in ClinicalTrials.gov with AqueSys, Inc. as lead sponsor.

NCT NCT02006693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02006693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Multicentric Evaluation of the AqueSys XEN Implant in Moderate Primary Open Angle Glaucoma Subjects
Lead sponsor
AqueSys, Inc.
Phase
Phase 4
Overall status
Completed
Start date
December 5, 2013
Completion date
January 26, 2017
Enrollment
199 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

primary open angle glaucoma